Research | Alzheimer's Prevention Registry

You are here

Home

Research

How was a woman destined to get Alzheimer’s protected by her genes?

A woman in Colombia was destined to develop Alzheimer’s disease in her 40’s because of a rare family genetic mutation. But she didn’t show symptoms until her 70’s. Scientists are now investigating what protected her from the memory stealing disease. Could her genes hold the key to new treatments?

Alzheimer’s Tests Soon May Be Common. Should You Get One?

Not long ago, the only way to know if someone had Alzheimer’s disease was to examine the brain in an autopsy.

Hope, Happiness And Social Connection: Hidden Benefits Of Regular Exercise

If ever there was a time to up your fitness game, the arrival of the new year and the new decade is it. But after the allure of the new gym membership wears off, our sedentary habits, more often than not, consume our promise of daily workouts. It doesn't have to be this way, says health psychologist and author, Kelly McGonigal.

Alzheimer’s and its impact on the African-American community

Alzheimer’s disease is a chronic neurodegenerative disease that usually starts slowly and gradually worsens over time. It is the cause of 60-70% of cases of dementia. In most cases, remembering recent events is one of the earliest symptoms. A disease in the brain, the onset usually occurs in patients over the age of 65 but can occur earlier. Alzheimer’s is one of the most financially costly diseases.

Frequent social contact in midlife may reduce dementia risk, Whitehall II study analysis shows

Frequent social contact—regularly seeing friends and family—during midlife was associated with a lower likelihood of dementia diagnosis in later life, according to a recent study in PLOS Medicine. Being socially engaged may require greater activity in areas of the brain that contribute to language and memory, which in turn may account for better cognitive health, the authors noted.

For Alzheimer’s Patient, Hope Renewed Following Biogen Announcement

When biotechnology company Biogen announced the cancellation of the trial for their Alzheimer’s drug aducanumab, nearly 3,500 trial participants were left in limbo. Now, following the company’s announcement that they will be reviving the trial, hope is blooming once again, particularly for those who felt the drug had a positive effect on their lives.

Drug curbs delusions, eases anger in Alzheimer's patients, researchers find

If regulators approve it, the drug could become the first new medicine for Alzheimer's patients in nearly two decades.
 

Obesity in Middle Age Raises Risk of Dementia

The exact causes behind dementia are varied and at times unclear. We know that genetic factors — like carrying the APOE4 gene — can have an impact on a person’s risk of developing Alzheimer’s, as can lifestyle or environmental factors like diet, exercise and exposure to air pollution. And a new study adds to the growing evidence that weight and obesity may also contribute to a person’s dementia risk.

Improve Memory and ‘Grey Matter’ in Your Brain Through Cardio Exercise

If you needed more motivation to get moving in the new year, a new study provides more evidence that exercise can help keep your brain healthy and functional, and possibly keep dementia and Alzheimer’s at bay.

Alzheimer’s Gene APOE4 Tied to Tau Protein in the Brain

Talk with an Alzheimer’s researcher and you’ll likely hear the same lament: Finding a treatment or cure is incredibly challenging because scientists are not even certain what exactly causes the neurological disease in the first place.